Latest
ProPharma Group Announces the Acquisition of Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and compliance & quality services to support pharmaceutical and biotechnology companies in obtaining and maintaining medicinal product licenses throughout all stages of a product’s life cycle.
read storyFeatured
Diamond Pharma Services provided EU regulatory support to Kite Pharma Inc.
The regulatory team within Diamond Pharma Services supported Kite Pharma Inc in European regulatory activities.
read storyOur latest article showcasing the opportunities for global medicines innovators in the UK
With a provisional EU-UK trade deal having been agreed, Diamond provide insight into the emerging standalone UK…
MHRA reveal that the UK will join Australia, Canada, Singapore and Switzerland to form the ACCESS consortium
Diamond Pharma Services provide Regulatory Services for the emerging stand-alone UK regulatory system Post-Brexit
Diamond will be exhibiting at the 4th Annual Gene Therapy for Rare Disorders Europe conference, online between 26-28…
Diamond supports GenSight Biologics in submitting its first Marketing Authorisation Application, for ocular gene…